Remifentanil Hydrochloride
Product Images NDC 75834-232

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 75834-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label-1mg Per Vial.jpg (Carton Label 1mg Per Vial)

FDA Label Image

Carton Label-2mg Per Vial.jpg (Carton Label 2mg Per Vial)

This is a label for Remifentanil Hydrochloride for Injection, to be used intravenously. The product is in single-dose vials and should only be administered as per prescription information. It provides details on dilution instructions, dosages, and storage conditions. The manufacturer is Nivagen Pharmaceutical. It is important to discard any unused portion of the drug.*

FDA Label Image

Carton Label-5mg Per Vial.jpg (Carton Label 5mg Per Vial)

This is an information sheet for Remifentanil Hydrochloride injection, containing details such as dosage, reconstitution instructions, storage guidelines, and manufacturer information. It is intended for intravenous use only and comes in single-dose vials. The text also includes important warnings about dilution and administration procedure. The barcode suggests modern inventory management practices may be implemented for tracking.*

FDA Label Image

Chemical Structure (Chemical Stracture)

FDA Label Image

Container Label-1mg Per Vial.jpg (Container Label 1mg Per Vial)

This text describes a medication with the NDC number 75834-230-01, which is Remifentanil Hydrochloride for Injection. Each vial contains 1 mg of the medication, and it is intended for intravenous use only. The medication is sterile and must be reconstituted and diluted before use. The usual dosage information can be found in the insert provided with the medication. Any unused portion should be discarded. The medication is manufactured by Nivagen Pharmaceuticals, Inc. in Sacramento, CA, USA. The revision date of production is February 2022.*

FDA Label Image

Container Label-2mg Per Vial.jpg (Container Label 2mg Per Vial)

FDA Label Image

Container Label-5mg Per Vial.jpg (Container Label 5mg Per Vial)

This is a pharmaceutical label for a sterile product that requires reconstitution and dilution before use. The medication is Hydrochloride with a usual dosage described in the insert. It is manufactured for Nivagen Pharmaceuticals, Inc. with a strength of 5 mg per vial. The product is for intravenous use only and is a single-dose vial. It has a batch number and an expiration date for tracking purposes.*

FDA Label Image

Figure 1.jpg (Figure 1)

This text provides information related to Minute Ventilation expressed as a percentage of baseline. It includes data points for two substances: Remifentanil Hydrochloride and Alfentanil, with 11 and 10 subjects respectively. The timeline spans over 270 minutes, showing the post-infusion effects of the substances over time.*

FDA Label Image

Figure 2.jpg (Figure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.